Brief: Geneuro End-Dec Net Cash Position Of Eur 5.5 Mln, Financial Visibility To Q1 2023

Geneuro SA

27/01/2022 06:42

Jan 27 (Reuters) - Geneuro SA  GNRO.PA :
    * GENEURO ANNOUNCES THE COMPLETION OF ITS PROTECT-MS STUDY
AND
CONFIRMS THE MARCH TIMELINE FOR TOP-LINE RESULTS, PROVIDES A
BUSINESS UPDATE AND CASH POSITION AS OF DECEMBER 31, 2021
    * TOP LINE RESULTS CONFIRMED FOR MARCH 2022
    * NET CASH POSITION OF EUR 5.5 MILLION AS OF DECEMBER 31,
2021
WITH FINANCIAL VISIBILITY TO Q1 2023
    * COMPLETION OF PROTECT-MS PHASE 2 CLINICAL TRIAL OF
TEMELIMAB IN
MULTIPLE SCLEROSIS (MS) WITH KAROLINSKA INSTITUTET / ACADEMIC
SPECIALIST CENTER OF STOCKHOLM

Source text for Eikon:  ID:nBwznckfa 
Further company coverage:  GNRO.PA 

 (Gdansk Newsroom)